Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation. (Q40392872)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Alexandru Saveanu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Michael D. Culler

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Manuela Albertelli

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Marica Arvigo

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Claudia Semino

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Philippe Jaquet

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

John E Taylor

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Jacques-Pierre Moreau

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Francesco Minuto

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Antonina Barreca

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

26 July 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

289

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

E1044-50

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16046458%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Somatostatin and Somatostatin Receptor Physiology

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Epidermal Growth Factor Induces the Functional Expression of Dopamine Receptors in the GH3 Cell Line*

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Somatostatin, its receptors and analogs, in lung cancer

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Somatostatin receptor subtype expression in human tissues: a prediction for diagnosis and treatment of cancer?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Somatostatin receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00209.2005

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40392872&oldid=1610278277"